Category Archives: "INforMS"

5 potential side effects of multiple sclerosis medications
Possible side effects for multiple sclerosis (MS) medications can range from mild to life-threatening.   When managing MS, health care [...]
New role of environment in multiple sclerosis revealed
Environmental factors may be playing a much greater role in the onset of multiple sclerosis (MS) than previously realised, according to [...]
Brain training video games ‘can soothe symptoms of multiple sclerosis’
Playing brain training video games can soothe symptoms of multiple sclerosis, say scientists. It boosts connections between neurons [...]
Can drinking lots of coffee lower risk for multiple scleorsis?
Coffee's possible health perks keep getting sweeter. In this case, a new study in the Journal of Neurology Neurosurgery & [...]
Ocrelizumab benefit in PPMS consistent in subgroups
NEW ORLEANS — A subgroup analysis of the phase 3 ORATORIO trial in primary progressive multiple sclerosis (PPMS) showed that ocrelizumab [...]
Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently
Walking with a wearable robotic exoskeleton may enable people with multiple sclerosis to walk more efficiently by reducing the energy and [...]
FDA grants breakthrough therapy for Ocrelizumab for PPMS
Press Release FDA grants Breakthrough Therapy Designation for GENENTECH’s investigational medicine ocrelizumab in primary progressive [...]
Multiple sclerosis patients may lose ability to taste
Many patients with multiple sclerosis (MS) lose the ability to distinguish different tastes -- a signal associated with MS-related lesions [...]
Multiple sclerosis study finds lipid antibodies reflect changes in brainvolume and lesions
Brigham and Women’s Hospital researchers reported that antibodies directed at lipids are associated with magnetic resonance imaging [...]
Multiple sclerosis patients seen to safely switch to oral drugs from injectable oral therapies
Stable multiple sclerosis (MS) patients do not appear to be at any increased risk of disease reactivation while switching to oral therapy [...]
  • (201) 487-1050
  • 3 University Plz Dr Ste 116, Hackensack, NJ 07601
  • info@mscare.org

Upcoming Testing Periods

WINTER 2024 TESTING PERIOD

Application Deadline: December 6th, 2023

First Day of Testing: Saturday, January 6th, 2024

Last Day of Testing: Saturday, January 20th, 2024

SUMMER 2024 TESTING PERIOD

Application Deadline: May 1st, 2024

First Day of Testing: Saturday, June 1st, 2024

Last Day of Testing: Saturday, June 15th, 2024

Resources

Visit PTC to download a PDF version of the Handbook. Candidates can also apply online.

For more information:

Professional Testing Corporation http://www.ptcny.com/

  • 212-356-0660
  • 1350 Broadway, 17th Floor, New York, NY 10018

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us





I have a question about

First

Last




Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM